Doctors often prescribe peptide therapies, such as GLP-1 receptor agonists, to improve insulin sensitivity
A clinical study published in JAMA demonstrated that tesamorelin produced a statistically significant reduction in visceral adipose tissue compared to placebo, with concurrent improvements in lipid profiles including triglycerides
On the other hand, coverage is usually much more common when semaglutide is prescribed for type 2 diabetes or to reduce cardiovascular risk
Many patients begin with injections for their once-weekly simplicity, then transition to oral tablets if needle anxiety emerges or if travel logistics favor daily pills
Are Compounded GLP-1's covered by insurance
GLP-1 medications are a class of drugs used primarily for treating type 2 diabetes and, more recently, for weight management